학술논문
Rheumatic immune- and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis
Document Type
Article
Author
Source
In: Revue du Rhumatisme (Edition Francaise) . (Revue du Rhumatisme (Edition Francaise), October 2022, 89(5):447-457)
Subject
Language
English
French
French
ISSN
11698330